Filed with ASX · · 2 pages · English
Starpharma Holdings Limited has announced the results of its Annual General Meeting held on November sixth, detailing the resolutions and voting outcomes for each item discussed. The filing includes information on the adoption of the remuneration report and the re-election of directors, along with the approval of performance rights plans. All resolutions presented at the meeting were carried, indicating shareholder support for the company's proposals.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
A SX A nnouncement Results of 2026 Annual General Meeting Melbourne, Australia; 6 November 2026: Starpharma (ASX: SPL, US OTC: SPHRY), today announces the details of the resolutions and the proxies and votes received in respect of each resolution at its Annual General Meeting (AGM), held today in...
Starpharma Holdings Limited on 6ix
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma